Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

SANUWAVE Health (SNWV) EBIAT (2016 - 2026)

SANUWAVE Health has reported EBIAT over the past 17 years, most recently at -$1.4 million for Q1 2026.

  • Quarterly EBIAT rose 76.48% to -$1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.5 million through Mar 2026, up 147.94% year-over-year, with the annual reading at $11.8 million for FY2025, 135.71% up from the prior year.
  • EBIAT was -$1.4 million for Q1 2026 at SANUWAVE Health, down from $7.7 million in the prior quarter.
  • Over five years, EBIAT peaked at $18.2 million in Q4 2023 and troughed at -$23.7 million in Q3 2023.
  • The 5-year median for EBIAT is -$4.8 million (2024), against an average of -$3.5 million.
  • The largest YoY upside for EBIAT was 420.08% in 2023 against a maximum downside of 1980.77% in 2023.
  • A 5-year view of EBIAT shows it stood at -$5.7 million in 2022, then surged by 420.08% to $18.2 million in 2023, then plummeted by 172.97% to -$13.3 million in 2024, then surged by 157.81% to $7.7 million in 2025, then plummeted by 118.71% to -$1.4 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's EBIAT are -$1.4 million (Q1 2026), $7.7 million (Q4 2025), and $9.7 million (Q3 2025).